Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Acquisitions (2024)

Biote (BTMD) has 1 years of Acquisitions data on record, last reported at $231000.0 in Q4 2024.

  • For Q4 2024, Acquisitions changed N/A year-over-year to $231000.0; the TTM value through Dec 2024 reached $11.8 million, changed N/A, while the annual FY2024 figure was $11.8 million, N/A changed from the prior year.
  • Acquisitions reached $231000.0 in Q4 2024 per BTMD's latest filing, down from $489000.0 in the prior quarter.
  • Across five years, Acquisitions topped out at $11.1 million in Q1 2024 and bottomed at $231000.0 in Q4 2024.